# Observational Post-Authorisation Safety Study of Asenapine (Sycrest)

> **NCT01734278** · — · COMPLETED · sponsor: **Professor Saad Shakir** · enrollment: 1000 (actual)

## Conditions studied

- Manic Disorder

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT01734278
- **Lead sponsor:** Professor Saad Shakir
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2017-01
- **Final completion:** 2018-01
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2018-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01734278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01734278, "Observational Post-Authorisation Safety Study of Asenapine (Sycrest)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01734278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*